Polycystic ovary syndrome in adolescence.

[1]  Julie Brown,et al.  Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. , 2009, The Cochrane database of systematic reviews.

[2]  R. Klein,et al.  Role of brain insulin receptor in control of body weight and reproduction. , 2006, Science.

[3]  E. Baracat,et al.  Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.

[4]  M. Quinkler,et al.  Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. , 2004, The Journal of endocrinology.

[5]  P. Pyett,et al.  Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility , 2004, The Lancet.

[6]  D. Jakubowicz,et al.  Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. , 2004, Fertility and sterility.

[7]  D. Ehrmann.  Polycystic ovary syndrome. , 2004, The New England journal of medicine.

[8]  W. Crowley,et al.  Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. , 2004, The Journal of clinical endocrinology and metabolism.

[9]  D. Dunger,et al.  Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. , 2004, The Journal of clinical endocrinology and metabolism.

[10]  D. Guzick.  Cardiovascular risk in PCOS. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  F. Orio,et al.  The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  C. De Geyter,et al.  Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  Y. Sadovsky,et al.  Insulin enhances the transcription of luteinizing hormone-β gene , 2004 .

[14]  H. Zisser,et al.  Screening for and Treatment of Polycystic Ovary Syndrome in Teenagers , 2004, Experimental biology and medicine.

[15]  P. Claman.  Men at risk: occupation and male infertility. , 2004, Fertility and sterility.

[16]  M. McCarthy,et al.  Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to Type 2 diabetes , 2004, Diabetologia.

[17]  K. Taylor,et al.  Androgen excess in women: experience with over 1000 consecutive patients. , 2004, The Journal of clinical endocrinology and metabolism.

[18]  D. Schoenfeld,et al.  Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. , 2004, The Journal of clinical endocrinology and metabolism.

[19]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.

[20]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Didier Dewailly,et al.  Ultrasound assessment of the polycystic ovary: international consensus definitions. , 2003, Human reproduction update.

[22]  M. Lawson,et al.  Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion. , 2003, The Journal of clinical endocrinology and metabolism.

[23]  D. Petitti.  Combination Estrogen–Progestin Oral Contraceptives , 2003 .

[24]  G. Chrousos,et al.  Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  D. Ray,et al.  Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency , 2003, Nature Genetics.

[26]  W. Dietz,et al.  Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of pediatrics & adolescent medicine.

[27]  J. Taieb,et al.  Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. , 2003, Clinical chemistry.

[28]  N. Goldenberg,et al.  Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. , 2003, Metabolism: clinical and experimental.

[29]  Richard S Legro,et al.  Polycystic ovary syndrome and cardiovascular disease: a premature association? , 2003, Endocrine reviews.

[30]  M. Fassnacht,et al.  Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.

[31]  S. Chew,et al.  The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. , 2003, The Journal of clinical endocrinology and metabolism.

[32]  N. Sattar,et al.  Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome , 2003, The Lancet.

[33]  R. Norman,et al.  Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. , 2003, The Cochrane database of systematic reviews.

[34]  T. Kawashima,et al.  Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.

[35]  H. Mason,et al.  Metformin has direct effects on human ovarian steroidogenesis. , 2003, Fertility and sterility.

[36]  R. Colman,et al.  Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. , 2003, Obesity research.

[37]  Jacqueline Akert.  A new generation of contraceptives. , 2003, RN.

[38]  J. Barrett,et al.  Heritability of features of the insulin resistance syndrome in a community‐based study of healthy families , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[39]  R. Legro,et al.  Molecular progress in infertility: polycystic ovary syndrome. , 2002, Fertility and sterility.

[40]  Samy I McFarlane,et al.  Metformin: An Update , 2002, Annals of Internal Medicine.

[41]  S. Franks,et al.  Developmental origin of polycystic ovary syndrome - a hypothesis. , 2002, The Journal of endocrinology.

[42]  P. Czernichow,et al.  Endocrine consequences of premature pubarche in post‐pubertal Caucasian girls , 2002, Clinical endocrinology.

[43]  B. Rich,et al.  Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. , 2002, The Journal of clinical endocrinology and metabolism.

[44]  J. Fiet,et al.  Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12‐month randomized trial , 2002, The British journal of dermatology.

[45]  J. Wood,et al.  The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. , 2001, The Journal of clinical endocrinology and metabolism.

[46]  C. Zouboulis,et al.  The SAHA Syndrome , 2001, Hormone Research in Paediatrics.

[47]  R. Rosenfield,et al.  Polycystic ovary syndrome and insulin-resistant hyperinsulinemia. , 2001, Journal of the American Academy of Dermatology.

[48]  J. Hall,et al.  Polycystic ovarian syndrome--relationship to epilepsy and antiepileptic drug therapy. , 2001, The Journal of clinical endocrinology and metabolism.

[49]  H. Escobar-Morreale,et al.  Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. , 2001, Diabetes care.

[50]  W. Miller,et al.  Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3β-Hydroxysteroid Dehydrogenase* , 2001, The Journal of Biological Chemistry.

[51]  J. Vandenbroucke,et al.  Oral contraceptives and the risk of venous thrombosis. , 2001, The New England journal of medicine.

[52]  S. Weitsman,et al.  Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. , 2001, The Journal of clinical endocrinology and metabolism.

[53]  R. Cobin,et al.  American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. , 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[54]  C. Dierickx.  Hair removal by lasers and intense pulsed light sources. , 2000, Seminars in cutaneous medicine and surgery.

[55]  T. Arora,et al.  Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. , 2000, The Journal of clinical endocrinology and metabolism.

[56]  M. Korbonits,et al.  How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? , 2000, Clinical endocrinology.

[57]  F. de Zegher,et al.  Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide. , 2000, The Journal of clinical endocrinology and metabolism.

[58]  R. Rosenfield,et al.  Role of hormones in pilosebaceous unit development. , 2000, Endocrine reviews.

[59]  P. G. Quinn,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Differential Activity of the Cytochrome P450 17�- Hydroxylase and Steroidogenic Acute Regulatory Protein Gene Promoters in Normal and Polycystic , 2022 .

[60]  R. Rosenfield,et al.  Hyperhidrosis as the only manifestation of hyperandrogenism in an adolescent girl. , 2000, Archives of dermatology.

[61]  R. Voutilainen,et al.  Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. , 2000, The Journal of clinical endocrinology and metabolism.

[62]  A. Dunaif,et al.  Selective insulin resistance in the polycystic ovary syndrome. , 1999, The Journal of clinical endocrinology and metabolism.

[63]  J. J. Mukherjee,et al.  Menstrual irregularity in women with acromegaly. , 1999, The Journal of clinical endocrinology and metabolism.

[64]  F. de Zegher,et al.  Anovulation after precocious pubarche: early markers and time course in adolescence. , 1999, The Journal of clinical endocrinology and metabolism.

[65]  R. Rosenfield.  Ovarian and adrenal function in polycystic ovary syndrome. , 1999, Endocrinology and metabolism clinics of North America.

[66]  R. Legro,et al.  Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. , 1999, Molecular endocrinology.

[67]  R. Norman,et al.  Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. , 1999, The Journal of clinical endocrinology and metabolism.

[68]  D. Driscoll,et al.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  F. de Zegher,et al.  Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. , 1998, The Journal of clinical endocrinology and metabolism.

[70]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[71]  S. Witchel,et al.  Variants of the type II 3beta-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents. , 1998, Molecular genetics and metabolism.

[72]  C. Invitti,et al.  Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome. , 1998, Metabolism: clinical and experimental.

[73]  J. Marshall,et al.  Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. , 1998, The Journal of clinical endocrinology and metabolism.

[74]  P. A. Lee,et al.  Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. , 1997, Biochemical and molecular medicine.

[75]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[76]  R. Kofler,et al.  CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. , 1997, Human molecular genetics.

[77]  S. Franks,et al.  Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome , 1997, Clinical endocrinology.

[78]  D. Ehrmann.  7 Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus , 1997 .

[79]  R. Rosenfield.  6 Current concepts of polycystic ovary syndrome , 1997 .

[80]  P. Schwingl.  Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease , 1996, British journal of obstetrics and gynaecology.

[81]  E. Porcu,et al.  Longitudinal Change of Sonographic Ovarian Aspects and Endocrine Parameters in Irregular Cycles of Adolescence , 1995, Pediatric Research.

[82]  W. Miller,et al.  Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[83]  R. Rosenfield.  Are adrenal and ovarian function normal in true precocious puberty? , 1995, European Journal of Endocrinology.

[84]  D. Apter,et al.  Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. , 1995, The Journal of clinical endocrinology and metabolism.

[85]  S. Franks,et al.  Polycystic ovary syndrome. , 1995, Archives of disease in childhood.

[86]  D. Ehrmann,et al.  Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. , 1995, Endocrine reviews.

[87]  Evaluation and treatment of hirsute women , 1995 .

[88]  Ø. Lidegaard.  Oral contraceptives, pregnancy and the risk of cerebra1 thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease , 1995, British journal of obstetrics and gynaecology.

[89]  L. Levitsky,et al.  Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. , 1994, The Journal of clinical endocrinology and metabolism.

[90]  S. Franks,et al.  Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. , 1994, The Journal of clinical endocrinology and metabolism.

[91]  J. Little,et al.  Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. , 1994, Human molecular genetics.

[92]  D. Apter,et al.  Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. , 1994, The Journal of clinical endocrinology and metabolism.

[93]  R. Azziz,et al.  Clinical review 56: Nonclassic adrenal hyperplasia: current concepts. , 1994, The Journal of clinical endocrinology and metabolism.

[94]  G. Huster,et al.  Acne Vulgaris in Premenarchal Girls: An Early Sign of Puberty Associated With Rising Levels of Dehydroepiandrosterone , 1994 .

[95]  S. Berga,et al.  Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation. , 1993, The Journal of clinical endocrinology and metabolism.

[96]  F. Keleştimur,et al.  17‐Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome , 1993, Clinical endocrinology.

[97]  L. Ibáñez,et al.  Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. , 1993, The Journal of clinical endocrinology and metabolism.

[98]  S. O’Rahilly,et al.  Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. , 1993, The Journal of clinical endocrinology and metabolism.

[99]  J. Nestler.  Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? , 1993, The Journal of clinical endocrinology and metabolism.

[100]  S. Franks,et al.  Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. , 1992, Clinical endocrinology.

[101]  D. Ehrmann,et al.  Detection of functional ovarian hyperandrogenism in women with androgen excess. , 1992, The New England journal of medicine.

[102]  R. Legro,et al.  Polycystic ovary syndrome. , 1992, Current therapy in endocrinology and metabolism.

[103]  D. Thompson,et al.  Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. , 1990, The Journal of clinical endocrinology and metabolism.

[104]  A. Dunaif,et al.  Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. , 1990, The Journal of clinical endocrinology and metabolism.

[105]  W. Rosner,et al.  The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. , 1990, Endocrine reviews.

[106]  J. Wadsworth,et al.  POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.

[107]  W. Futterweit,et al.  Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. , 1986, The Journal of clinical endocrinology and metabolism.

[108]  J. Price,et al.  MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE , 1985, The Lancet.

[109]  R. Wild,et al.  Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. , 1983, American journal of obstetrics and gynecology.

[110]  G. W. Moll,et al.  Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. , 1983, The Journal of pediatrics.

[111]  R. Bergenstal,et al.  Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. , 1982, The Journal of clinical endocrinology and metabolism.

[112]  M. Kim,et al.  Hirsutism: implications, etiology, and management. , 1981, American journal of obstetrics and gynecology.

[113]  G. W. Moll,et al.  Testosterone binding and free plasma androgen concentrations under physiological conditons: chararacterization by flow dialysis technique. , 1979, The Journal of clinical endocrinology and metabolism.

[114]  D. Krieger,et al.  Pituitary tumors associated with hyperprolactinemia and polycystic ovarian disease. , 1979, Fertility and sterility.

[115]  R. Rosenfield.  Plasma free androgen patterns in hirsute women and their diagnostic implications. , 1979, The American journal of medicine.

[116]  D. Apter,et al.  Serum pregnenolone, progesterone, 17-hydroxyprogesterone, testosterone and 5 alpha-dihydrotestosterone during female puberty. , 1977, The Journal of clinical endocrinology and metabolism.

[117]  R. Habershon.  Letter: Kumidini hospital. , 1975, Lancet.

[118]  R. Richart,et al.  The prognosis for adolescents with menstrual abnormalities. , 1966, American journal of obstetrics and gynecology.

[119]  Y. Sadovsky,et al.  Insulin enhances the transcription of luteinizing hormone-beta gene. , 2004, American Journal of Obstetrics and Gynecology.

[120]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[121]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[122]  D. Petitti.  Clinical practice. Combination estrogen-progestin oral contraceptives. , 2003, The New England journal of medicine.

[123]  R. Azziz,et al.  Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. , 2001, Fertility and sterility.

[124]  D. Ehrmann,et al.  Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. , 2000, Journal of pediatric endocrinology & metabolism : JPEM.

[125]  W. Dodson,et al.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. , 1999, The Journal of clinical endocrinology and metabolism.

[126]  M. Cavaghan,et al.  Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. , 1999, Diabetes care.

[127]  R. Clayton,et al.  Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. , 1999, The Journal of clinical endocrinology and metabolism.

[128]  G. Morgante,et al.  Hormonal effects of flutamide in young women with polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.

[129]  D. Ehrmann.  Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus. , 1997, Bailliere's clinical obstetrics and gynaecology.

[130]  R. Rosenfield.  Current concepts of polycystic ovary syndrome. , 1997, Bailliere's clinical obstetrics and gynaecology.

[131]  K. Nonaka.  [Idiopathic hirsutism]. , 1993, Ryoikibetsu shokogun shirizu.

[132]  R. Pasquali,et al.  Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. , 1989, The Journal of clinical endocrinology and metabolism.

[133]  G. Okoev,et al.  [Diagnostic criteria for polycystic ovary syndrome]. , 1989, Akusherstvo i ginekologiia.

[134]  A. Treloar,et al.  Variation of the human menstrual cycle through reproductive life. , 1967, International journal of fertility.